ArticleBioengineering (Basel, Switzerland)2026
Mamba-Bi-LSTM with SHAP-Guided Iterative Refinement for Multimodal ARDS Diagnosis: A Dual-System Framework.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Acute respiratory distress syndrome (ARDS) is associated with mortality rates up to 46% and remains challenging to diagnose early due to overlapping clinical presentations. We propose a dual-system framework for multimodal ARDS diagnosis that integrates a Mamba-Bi-LSTM primary discrimination system with a TreeSHAP-based verification system whose attribution outputs iteratively refine the primary system's feature selection gate. The primary system processes heterogeneous clinical inputs-ventilator parameters, blood gas indices, chest imaging, and EEG signals-through a selective state-space Mamba module and bidirectional LSTM layers. The verification system applies TreeSHAP attribution to independently cross-validate primary outputs, provide clinically interpretable evidence, and supply ℓ1-normalised attribution vectors that directly modulate the Mamba feature selection gate weights during offline refinement. A confidence-and-consistency decision mechanism governs final output, and high-confidence predictions are incorporated as curriculum-filtered signals to iteratively recalibrate both systems through a confidence-gated offline refinement protocol. Evaluated on 3742 held-out patients from MIMIC-IV (internal test) and 2594 patients from the eICU Collaborative Research Database across 208 US hospitals (external validation), the complete system achieves 92.8% accuracy and an F1 score of 0.889 after offline iterative recalibration on the internal test set, with 91.6% accuracy and F1 of 0.871 on external validation, extending early warning time from 5.2 to 9.7 h. The P/F ratio consistently ranks as the top predictive feature in alignment with the Berlin definition. Ablation experiments confirm that EEG integration independently contributes a 2.7 percentage point accuracy gain and a 1.9-h extension of the warning window (McNemar χ2=27.0, p<0.001). All performance improvements over single-modality baselines and over existing methods are statistically significant (p<0.001, Bonferroni-corrected). End-to-end processing latency of 350 ms per case is compatible with real-time ICU deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.